01335nam 2200373Ia 450 991069691540332120230902161631.0(CKB)5470000002383742(OCoLC)565949861(EXLCZ)99547000000238374220100322d2003 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information[Rockville, MD] :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2003]1 electronic resource (24 pages)"CMC.""May 2003."Includes bibliographical references (pages 23-24).Guidance for industry Medicine, ExperimentalGovernment policyUnited StatesDrug approvalUnited StatesMedicine, ExperimentalGovernment policyDrug approvalCenter for Drug Evaluation and Research (U.S.)GPOGPOBOOK9910696915403321Guidance for industry3434577UNINA